BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 5049143)

  • 1. Fatty acid composition of the sterol ester fraction of human adrenal cortex in Cushingś syndrome and after treatment with aminoglutethimide.
    Raggatt PR; Engel LL; Symington T
    Lipids; 1972 Jul; 7(7):474-82. PubMed ID: 5049143
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of elipten in Itsenko-Cushing disease (preliminary report)].
    Marova EI; Lemesheva SN
    Probl Endokrinol (Mosk); 1970; 16(5):7-10. PubMed ID: 5520275
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical experiences with aminoglutethimide (Elipten), a new inhibitor of steroid biosynthesis in the adrenal gland].
    Horký K; Küchel O; Gregorová I; Jiránková J; Matys Z
    Schweiz Med Wochenschr; 1968 Nov; 98(47):1843-51. PubMed ID: 4236505
    [No Abstract]   [Full Text] [Related]  

  • 4. Aminoglutethimide: a "side-effect" turned to therapeutic advantage.
    Hughss SW; Burley DM
    Postgrad Med J; 1970 Jul; 46(537):409-16. PubMed ID: 4920933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical and biological study of an inhibitor of adrenocortical hormone synthesis: aminoglutethinide].
    Philbert M; Laudat MH; Laudat P; Bricaire H
    Ann Endocrinol (Paris); 1968; 29(2):189-210. PubMed ID: 4298418
    [No Abstract]   [Full Text] [Related]  

  • 6. The treatment of congenital adrenal hyperplasia with aminoglutethimide.
    Hamilton W
    Q J Med; 1971 Oct; 40(160):568-9. PubMed ID: 5157412
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of aminoglutethimide and reserpine on the human pituitary-adrenal axis: remission of a case of Cushing's disease.
    Givens JR; Camacho A; Patterson P
    Metabolism; 1970 Oct; 19(10):818-30. PubMed ID: 4918596
    [No Abstract]   [Full Text] [Related]  

  • 8. Fluctuating Cushing's syndrome, acute psychosis, aminoglutethimide therapy.
    Barnett IG; Nabarro JD; LeQuesne LP
    Proc R Soc Med; 1970 Apr; 63(4):338-9. PubMed ID: 5441960
    [No Abstract]   [Full Text] [Related]  

  • 9. [A case of Cushing's disease treated by aminoglutethimide].
    Thevenet M; Lumbroso P; Netter A
    Ann Endocrinol (Paris); 1968; 29(3):346-50. PubMed ID: 4326387
    [No Abstract]   [Full Text] [Related]  

  • 10. The treatment of congenital adrenal hyperplasia with aminoglutethimide.
    Hamilton W; Moodie T
    Dev Med Child Neurol; 1970 Oct; 12(5):618-28. PubMed ID: 5477945
    [No Abstract]   [Full Text] [Related]  

  • 11. Qualitative alterations in urinary 17-ketosteroid excretion during aminoglutethimide administration.
    Horký K; Küchel O; Gregorvá I; Stárka L
    J Clin Endocrinol Metab; 1969 Feb; 29(2):297-9. PubMed ID: 4236926
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy of amino-glutethimide in the ectopic ACTH syndrome.
    Gorden P; Becker CE; Levey GS; Roth J
    J Clin Endocrinol Metab; 1968 Jun; 28(6):921-3. PubMed ID: 4172920
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of ACTH and aminoglutethimide on cholesterol metabolism in sheep adrenal cortex in vitro.
    Shaefer JM; Gans JH
    Endocrinology; 1972 Mar; 90(3):787-94. PubMed ID: 4333147
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of aminoglutethimide in a case of ectopic ACTH syndrome. Influence on steroid metabolism.
    McMillan M; Maisey MN
    Acta Endocrinol (Copenh); 1970 Aug; 64(4):676-86. PubMed ID: 4318105
    [No Abstract]   [Full Text] [Related]  

  • 15. [The effect of eliptene aminoglutethimide on the excretion of gonadotropins and phenol steroids (preliminary study)].
    Dil'man VM; Krylova NV; Tsyrlina EV; Vishnevskiĭ AS
    Vopr Onkol; 1969; 15(3):94-5. PubMed ID: 5406696
    [No Abstract]   [Full Text] [Related]  

  • 16. [Corticosteroidogenesis inhibitors. II. A new cortico-adrenal inhibitor: amino-glutethimide (16,038Ba)].
    Philbert M; Luton JP; Mathieu de Fossey B; Bricaire H
    Presse Med (1893); 1968 May; 76(23):1107-10. PubMed ID: 5657304
    [No Abstract]   [Full Text] [Related]  

  • 17. Topical aminoglutethimide and sebum excretion.
    Burton JL; Cartlidge M; Shuster S
    Br J Dermatol; 1971 Oct; 85(4):400-1. PubMed ID: 4256642
    [No Abstract]   [Full Text] [Related]  

  • 18. Aminoglutethimide (Elipten-Ciba) as an inhibitor of adrenal steroidogenesis: mechanism of action and therapeutic trial.
    Cash R; Brough AJ; Cohen MN; Satoh PS
    J Clin Endocrinol Metab; 1967 Sep; 27(9):1239-48. PubMed ID: 4292247
    [No Abstract]   [Full Text] [Related]  

  • 19. [Aminoglutethimide-induced lipoid transformation of mitochondria in the adrenal cortex].
    Marek J; Thoenes W; Motlík K
    Naturwissenschaften; 1970 May; 57(5):250-1. PubMed ID: 5426035
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of aminoglutethimide on lipid fractions in rat adrenals.
    Macho L; Palkovic M; Zbuzek V; Zbuzková-Kmentová V; Schreiber V
    Endocrinol Exp; 1970; 4(3):165-70. PubMed ID: 4328930
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.